I just returned from the ACOG Annual Meeting in San Francisco (American College of Obstetricians and Gynecologists).  Imagine spending three days in an exhibit hall filled with every product and gadget your gynecologist could ever want or need.  I’ll leave it up to your imagination!

In my ideal world, I would have liked to have seen many more treatments and drug therapies for uterine fibroids.  Considering the prevalence of uterine fibroids and the frequency in which gynecologists treat patients with fibroids, I was disappointed by the lack of attention placed on such a significant women’s health issue.  Someone is clearly not paying attention!

But some good news – I was wrong.  There are a few people paying attention.

Halt Medical is currently in clinical trials for a new minimally invasive treatment designed for use by gynecologists that will utilize volumetric radiofrequency ablation to treat fibroids.  This would expand treatment options currently available and give you, the patient, a possible new option.  I watched a simulation of this laparoscopic procedure and it was quite fascinating.  We’ll be posting more information about this very soon, including information on how to find out more about their clinical trials.

There is also a new FDA approved non-hormonal therapy available to treat heavy menstrual bleeding – tranexamic acid tablets marketed under Lysteda.  Lysteda works by stabilizing a protein that helps blood to clot.  Studies have shown that the therapy can provide significant reduction in menstrual blood loss which may be of HUGE significance to many women suffering from uterine fibroids.  I would encourage you to ask your physician about this therapy to see if it could work for you.

Remember that there is HOPE for uterine fibroids and you can find RELIEF.  We’re committed to keep you up-to-date on all the latest developments with new treatments, as they become available.

Until next time,

Tina